More Healthcare Coverage
-
April 15, 2026
'A Bunch Of Games': MDL Judge Irked By Meta, AGs Sparring
A California federal judge appeared skeptical Wednesday of Meta Platforms Inc.'s request for a summary judgment win over claims by state attorneys general in multidistrict social media addiction litigation, saying repeatedly that many disputes should be resolved at trial and panning some arguments by both sides as "a bunch of games."
-
April 15, 2026
Hims & Hers Providers Can't Duck Suit Over Student's Suicide
Medical providers for telehealth company Hims & Hers can't escape a wrongful death lawsuit from the family of a Washington State University freshman who died by suicide in 2023, according to a Washington state judge's order denying summary judgment motions from five individual defendants.
-
April 15, 2026
'Law, Not Liturgy'?: 9th Circ. Split Over Faith Bias COVID Suit
Eight judges dissented Wednesday from the denial of an en banc Ninth Circuit rehearing of a panel's decision not to revive a Christian hospital worker's religious bias lawsuit alleging she was fired for refusing COVID-19 nasal testing, with one dissenting judge saying "courts are unwelcome guests" when deciding the veracity of an individual's belief.
-
April 15, 2026
Judge Won't Move 'Maya' Case For Retrial
A Florida judge on Wednesday denied a hospital's request to move a retrial of Netflix documentary subject Maya Kowalski's claims against the hospital from Sarasota to St. Petersburg, citing the difficulty and expense of moving the 8-year-old case to a new circuit and judge.
-
April 15, 2026
Fertility Biz Progyny Hit With TM Suit In Pennsylvania
Fertility benefit management company Progyny Inc.'s expansion into pregnancy and postpartum care while using the "Progyny" trademark will create confusion in the marketplace by overlapping with similar but differently spelled marks, a new lawsuit from ProgenyHealth LLC claims.
-
April 15, 2026
Fed. Circ. Won't Make It Harder To Undo CICA Stay Overrides
The Federal Circuit declined to impose a heightened standard of review when judges are considering a federal agency's decision to override an automatic pause on contract performance during a bid protest at the U.S. Government Accountability Office.
-
April 14, 2026
Wash. Appeals Court Revives Podiatrist Trade Secrets Case
An appeals court in Washington state has reinstated a case brought by a Seattle-area podiatry practice against a former employee accused of stealing patient data for his separate practice.
-
April 14, 2026
Buyers Seek Final Approval Of $4.85M Bayer Benzene Deal
A class of consumers is asking a New Jersey federal court to give final approval of a $4.85 million settlement to resolve claims that Bayer US LLC's antifungal products were contaminated with benzene.
-
April 13, 2026
Hikma Tells Justices Cox Ruling Boosts 'Skinny Label' Case
Hikma Pharmaceuticals USA Inc. told the U.S. Supreme Court on Monday that the justices' recent decision clearing an internet company in a copyright case bolsters the drugmaker's challenge to a patent suit over its generic version of an Amarin Pharma Inc. heart drug.
-
April 13, 2026
AI Cardiac Imaging Co. Hits Ex-Consultant With IP Suit
Artificial intelligence-powered cardiac imaging company Heartflow Inc. filed patent infringement and trade secret misappropriation claims on Monday against a competitor founded by a former consultant who, the company says, lifted technological trade secrets while he was under contract.
-
April 13, 2026
Holland & Knight Adds Healthcare Pro In Dallas From Dykema
Holland & Knight LLP announced Monday that it has deepened its healthcare transactions practice with a Dallas-based partner who came aboard from Dykema Gossett PLLC.
-
April 10, 2026
Allstate Says Texas Family Stole $7.9M In Medical Billing Scam
A Texas family and their collection of companies carried out a scheme to defraud Allstate out of $7.9 million by submitting false records and bills for unnecessary medical services purportedly provided to motor vehicle crash victims, the insurer alleged in a suit filed in Texas federal court Friday.
-
April 10, 2026
Chinese Scholar Gets Time Served For Smuggling E. Coli DNA
A Chinese postdoctoral research associate at Indiana University was sentenced to time served on Wednesday by an Indiana federal judge, spending more than four months in custody on smuggling charges for shipping an E. coli sample from China into the U.S. and lying about it when questioned by U.S. Customs and Border Protection agents.
-
April 09, 2026
Swiss Firm Says Clause Required Zurich Hospital Arbitration
A D.C. federal judge is being called upon to again enforce a roughly $8.6 million arbitral award issued against Equatorial Guinea in a dispute over an ill-fated hospital operating contract, months after his initial enforcement ruling was overturned by the D.C. Circuit.
-
April 09, 2026
Clinic Charged Patients For Faulty Mammograms, Suit Claims
A West Virginia clinic provided "worthless" mammograms to hundreds of patients for more than two years, according to a proposed class action filed in federal court which seeks refunds and other damages in excess of $5 million.
-
April 09, 2026
Merck Beats 295 Zostavax Suits Over Missed Deadlines
A Pennsylvania federal judge has tossed 295 cases against Merck & Co. Inc. in the multidistrict litigation alleging its Zostavax shingles vaccine caused the disease, with the court reasoning that the plaintiffs' inactivity doomed the cases.
-
April 15, 2026
The 2026 Lawyer Satisfaction Survey: Where Do You Stand?
How is your work-life balance? Are you content with your compensation and opportunities for advancement at work? Take the 2026 Law360 Lawyer Satisfaction Survey and share your thoughts.
-
April 09, 2026
Ex-Pharmacy Director Denies Using Trade Secrets At New Job
A former director at a specialty infusion therapy pharmacy urged a New Jersey federal court to reject her former employer's bid to block her from working for a rival, arguing that her new job does not pose any threat of imminent harm to her former company.
-
April 09, 2026
Colo. Co. Failed To Prevent Patient Data Leak, Suit Says
A Colorado-based digital health company focused on reversing Type 2 diabetes is facing a proposed class action in federal court alleging it did not protect patients' personal and medical information from a cyberattack in late March that exposed their information to the dark web.
-
April 08, 2026
Fla. Insurer, Ex-Parent To Pay $135M Over ACA Fraud Scheme
A Florida insurer and its former parent, which is a Delaware-based national partnership of insurance brokers, have agreed to pay $135 million collectively to resolve allegations of a scheme to enroll ineligible consumers into subsidized Affordable Care Act plans and of defrauding the federal government of more than $140 million.
-
April 08, 2026
No Surprises Act Bars Provider's Award Enforcement Bid
A Pennsylvania federal court declined to force an insurer to pay over $300,000 in alleged outstanding payments from an out-of-network billing dispute with a provider, finding it lacked authority to do so under the No Surprises Act.
-
April 08, 2026
Lost Data Should Get Co. Punished In EEOC Suit, Judge Says
A Georgia federal judge recommended sanctions against a cosmetic surgery provider for neglecting to keep sales data and messages, saying the information could've been relevant in a disability bias suit the U.S. Equal Employment Opportunity Commission brought on a former worker's behalf.
-
April 08, 2026
Abbott Urges Ill. Jury To Reject Claims Formula Led To NEC
Counsel for Abbott Laboratories told an Illinois jury Wednesday that four infants, whose mothers allege the company's preterm baby formula caused their serious intestinal illness, would have developed the disease "even without a drop of formula" given other risk factors and that the absence of other feeding options at the time of the babies' births dooms their parents' claims.
-
April 07, 2026
Insurer Premera Accuses Clinic Of Misusing No Surprises Act
Premera Blue Cross sued a weight loss clinic on Monday in Washington federal court saying it abused a federal law aimed at safeguarding patients from unexpected medical bills in order to shake down the insurer for exorbitant amounts of money — as much as 10 times what Premera pays in-network providers.
-
April 07, 2026
Ga. Panel Vacates $662K Interest On $2M Arbitration Award
A Georgia Court of Appeals panel on Tuesday vacated about $662,000 in interest that was tacked onto an arbitration award in a trade secrets dispute between two medical device companies, ruling that while the assessment of interest was justified, a trial court had miscalculated the total.
Expert Analysis
-
Class Actions At The Circuit Courts: April Lessons
In this month's review of class action appeals, Mitchell Engel at Shook Hardy identifies practice tips from three recent rulings involving allegations of racial discrimination in mortgage applications, health insurance networks and actual cash value losses.
-
Judicial Restraint Anchors Constitutional Order
Contrasting opinions in two recent U.S. Supreme Court rulings — Trump v. CASA and Bost v. Illinois State Board of Elections — demonstrate how the judiciary’s constitutionally entrusted role can easily be preserved or disrupted, and invite renewed attention to the enduring importance of judicial restraint, says Ninth Circuit Judge J. Clifford Wallace.
-
What A Court Doc Audit Reveals About Erroneous Filings
My audit of 1,522 court documents from last month found that over 95% contained at least one verifiable error, with fewer than 1% showing clear indicators of artificial intelligence use — highlighting above all else that lawyers may want to focus most on strengthening their review processes, says Elliott Ash at ETH Zurich.
-
Similar-Looking Designs May Not Always Prove Infringement
The Federal Circuit's recent decision in Range of Motion Products v. Armaid is a reminder that even a strikingly similar design might not be found to infringe upon a patented design once design features driven by functionality are filtered out from consideration, say attorneys at BCLP.
-
Determining When Engineered Biologics May Be Patentable
The Federal Circuit's recent decision in Regenxbio v. Sarepta, concluding that engineered cells with DNA from different organisms are not patent-ineligible natural phenomena, raises questions surrounding what framework courts will use to evaluate the patent eligibility of engineered biologics moving forward, says Robert Frederickson at Goodwin.
-
Getting The Most Out Of Learning And Development Programs
Excerpt from Practical Guidance
Junior associates can better develop the legal, business and interpersonal skills they need for long-term success by approaching their firms’ learning and development programs armed with five tips for getting the most out of these resources, says Lauren Hakala at Reed Smith.
-
AI Presents A Make-Or-Break Moment For Outside Counsel
The rapid adoption of artificial intelligence by corporate legal departments is forcing a long-overdue reset of the relationship between inside and outside counsel, and introducing a significant opportunity to shed frustrating inefficiencies and strengthen collaboration for firms willing to embrace the shift, says Intel Chief Legal Officer April Miller Boise.
-
5 Tips For Navigating Your Firm's All-Attorney Summit
Excerpt from Practical Guidance
Law firm retreats should be approached strategically, as they present valuable opportunities to advance both the firm's objectives and attorneys' professional development through meaningful participation, building and strengthening internal relationships, and proactive follow-up, says James Argionis at Cozen O’Connor.
-
Law School's Missed Lessons: The Human Element
Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.
-
The Benefits Of Choosing A Niche Practice In The AI Age
As artificial intelligence becomes increasingly accessible, lawyers with a niche practice may stand out as clients seek specialized judgment that automation cannot replicate, but it is important to choose a niche that is durable, engaging and a good personal fit, says Daniel Borneman at Lowenstein Sandler.
-
Job Shift Accommodation Ruling Clarifies 'Essential Function'
In Siebrecht v. Mercy Health-Iowa, the Eighth Circuit's recent denial of a disabled worker's shift exemption request shows that the essential function of a job can encompass more than core job requirements and include things like scheduling flexibility, says Kim Kirn at Miles Mediation & Arbitration.
-
Fed. Circ. Must Bury Design Patent Doctrinal Zombies
After recently finding noninfringement in Range of Motion Products v. Armaid, the Federal Circuit must rehear the case to confront two troublesome doctrines of design patent law claim construction — feature filtration and claim verbalization — that have lingered for decades and intensified in recent years, say attorneys at McAndrews Held.
-
Why Mukherji Won't End USCIS' EB-1A Two-Step
A Nebraska federal court's recent decision in Mukherji v. Miller seemed to vindicate longstanding complaints about the U.S. Citizenship and Immigration Services' controversial two-step adjudication process, declaring the framework unlawful — but Mukherji is unlikely to be the death blow that immigration practitioners have hoped for, says Jun Li at Reid & Wise.